Medical Care
Global Recombinant DNA (rDNA) Technology Market Research Report 2025
- Jul 08, 25
- ID: 348262
- Pages: 82
- Figures: 81
- Views: 1
The global market for Recombinant DNA (rDNA) Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant DNA (rDNA) Technology in Biotechnology and Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant DNA (rDNA) Technology include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant DNA (rDNA) Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA (rDNA) Technology.
The Recombinant DNA (rDNA) Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant DNA (rDNA) Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant DNA (rDNA) Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
Segment by Type
Expression System
Cloning Vector
Segment by Application
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant DNA (rDNA) Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant DNA (rDNA) Technology in Biotechnology and Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant DNA (rDNA) Technology include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant DNA (rDNA) Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA (rDNA) Technology.
The Recombinant DNA (rDNA) Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant DNA (rDNA) Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant DNA (rDNA) Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
Segment by Type
Expression System
Cloning Vector
Segment by Application
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant DNA (rDNA) Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Expression System
1.2.3 Cloning Vector
1.3 Market by Application
1.3.1 Global Recombinant DNA (rDNA) Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic and Government Research Institutes
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA (rDNA) Technology Market Perspective (2020-2031)
2.2 Global Recombinant DNA (rDNA) Technology Growth Trends by Region
2.2.1 Global Recombinant DNA (rDNA) Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Size by Region (2020-2025)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2026-2031)
2.3 Recombinant DNA (rDNA) Technology Market Dynamics
2.3.1 Recombinant DNA (rDNA) Technology Industry Trends
2.3.2 Recombinant DNA (rDNA) Technology Market Drivers
2.3.3 Recombinant DNA (rDNA) Technology Market Challenges
2.3.4 Recombinant DNA (rDNA) Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2020-2025)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant DNA (rDNA) Technology Revenue
3.4 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2024
3.5 Global Key Players of Recombinant DNA (rDNA) Technology Head office and Area Served
3.6 Global Key Players of Recombinant DNA (rDNA) Technology, Product and Application
3.7 Global Key Players of Recombinant DNA (rDNA) Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA (rDNA) Technology Breakdown Data by Type
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Type (2020-2025)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2026-2031)
5 Recombinant DNA (rDNA) Technology Breakdown Data by Application
5.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Application (2020-2025)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2020-2031)
6.2 North America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2020-2031)
7.2 Europe Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size (2020-2031)
8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant DNA (rDNA) Technology Market Size (2020-2031)
9.2 Latin America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
9.4 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size (2020-2031)
10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
11.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
11.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
11.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
11.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
11.2 Profacgen
11.2.1 Profacgen Company Details
11.2.2 Profacgen Business Overview
11.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
11.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.2.5 Profacgen Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
11.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.3.5 Amgen Inc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
11.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
11.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.5.5 GenScript Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
11.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.6.5 Pfizer Inc Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Details
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
11.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
11.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.8.5 Eli Lilly and Company Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
11.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Biocon
11.10.1 Biocon Company Details
11.10.2 Biocon Business Overview
11.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
11.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.10.5 Biocon Recent Development
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Company Details
11.11.2 GlaxoSmithKline plc Business Overview
11.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
11.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.11.5 GlaxoSmithKline plc Recent Development
11.12 New England Biolabs.
11.12.1 New England Biolabs. Company Details
11.12.2 New England Biolabs. Business Overview
11.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
11.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.12.5 New England Biolabs. Recent Development
11.13 Cibus
11.13.1 Cibus Company Details
11.13.2 Cibus Business Overview
11.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
11.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.13.5 Cibus Recent Development
11.14 Monsanto Company
11.14.1 Monsanto Company Company Details
11.14.2 Monsanto Company Business Overview
11.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
11.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.14.5 Monsanto Company Recent Development
11.15 Horizon Discovery Group PLC
11.15.1 Horizon Discovery Group PLC Company Details
11.15.2 Horizon Discovery Group PLC Business Overview
11.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
11.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.15.5 Horizon Discovery Group PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Expression System
1.2.3 Cloning Vector
1.3 Market by Application
1.3.1 Global Recombinant DNA (rDNA) Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic and Government Research Institutes
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA (rDNA) Technology Market Perspective (2020-2031)
2.2 Global Recombinant DNA (rDNA) Technology Growth Trends by Region
2.2.1 Global Recombinant DNA (rDNA) Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Size by Region (2020-2025)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2026-2031)
2.3 Recombinant DNA (rDNA) Technology Market Dynamics
2.3.1 Recombinant DNA (rDNA) Technology Industry Trends
2.3.2 Recombinant DNA (rDNA) Technology Market Drivers
2.3.3 Recombinant DNA (rDNA) Technology Market Challenges
2.3.4 Recombinant DNA (rDNA) Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2020-2025)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant DNA (rDNA) Technology Revenue
3.4 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2024
3.5 Global Key Players of Recombinant DNA (rDNA) Technology Head office and Area Served
3.6 Global Key Players of Recombinant DNA (rDNA) Technology, Product and Application
3.7 Global Key Players of Recombinant DNA (rDNA) Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA (rDNA) Technology Breakdown Data by Type
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Type (2020-2025)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2026-2031)
5 Recombinant DNA (rDNA) Technology Breakdown Data by Application
5.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Application (2020-2025)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2020-2031)
6.2 North America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2020-2031)
7.2 Europe Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size (2020-2031)
8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant DNA (rDNA) Technology Market Size (2020-2031)
9.2 Latin America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
9.4 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size (2020-2031)
10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
11.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
11.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
11.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
11.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
11.2 Profacgen
11.2.1 Profacgen Company Details
11.2.2 Profacgen Business Overview
11.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
11.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.2.5 Profacgen Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
11.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.3.5 Amgen Inc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
11.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
11.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.5.5 GenScript Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
11.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.6.5 Pfizer Inc Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Details
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
11.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
11.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.8.5 Eli Lilly and Company Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
11.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Biocon
11.10.1 Biocon Company Details
11.10.2 Biocon Business Overview
11.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
11.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.10.5 Biocon Recent Development
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Company Details
11.11.2 GlaxoSmithKline plc Business Overview
11.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
11.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.11.5 GlaxoSmithKline plc Recent Development
11.12 New England Biolabs.
11.12.1 New England Biolabs. Company Details
11.12.2 New England Biolabs. Business Overview
11.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
11.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.12.5 New England Biolabs. Recent Development
11.13 Cibus
11.13.1 Cibus Company Details
11.13.2 Cibus Business Overview
11.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
11.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.13.5 Cibus Recent Development
11.14 Monsanto Company
11.14.1 Monsanto Company Company Details
11.14.2 Monsanto Company Business Overview
11.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
11.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.14.5 Monsanto Company Recent Development
11.15 Horizon Discovery Group PLC
11.15.1 Horizon Discovery Group PLC Company Details
11.15.2 Horizon Discovery Group PLC Business Overview
11.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
11.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.15.5 Horizon Discovery Group PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Expression System
Table 3. Key Players of Cloning Vector
Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Recombinant DNA (rDNA) Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Recombinant DNA (rDNA) Technology Market Share by Region (2020-2025)
Table 8. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Recombinant DNA (rDNA) Technology Market Share by Region (2026-2031)
Table 10. Recombinant DNA (rDNA) Technology Market Trends
Table 11. Recombinant DNA (rDNA) Technology Market Drivers
Table 12. Recombinant DNA (rDNA) Technology Market Challenges
Table 13. Recombinant DNA (rDNA) Technology Market Restraints
Table 14. Global Recombinant DNA (rDNA) Technology Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Players (2020-2025)
Table 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2024)
Table 17. Ranking of Global Top Recombinant DNA (rDNA) Technology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Recombinant DNA (rDNA) Technology Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Recombinant DNA (rDNA) Technology, Headquarters and Area Served
Table 20. Global Key Players of Recombinant DNA (rDNA) Technology, Product and Application
Table 21. Global Key Players of Recombinant DNA (rDNA) Technology, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant DNA (rDNA) Technology Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2020-2025)
Table 25. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2026-2031)
Table 27. Global Recombinant DNA (rDNA) Technology Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2020-2025)
Table 29. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2026-2031)
Table 31. North America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
Table 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
Table 48. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product
Table 49. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
Table 51. Profacgen Company Details
Table 52. Profacgen Business Overview
Table 53. Profacgen Recombinant DNA (rDNA) Technology Product
Table 54. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 55. Profacgen Recent Development
Table 56. Amgen Inc Company Details
Table 57. Amgen Inc Business Overview
Table 58. Amgen Inc Recombinant DNA (rDNA) Technology Product
Table 59. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 60. Amgen Inc Recent Development
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Recombinant DNA (rDNA) Technology Product
Table 64. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. GenScript Company Details
Table 67. GenScript Business Overview
Table 68. GenScript Recombinant DNA (rDNA) Technology Product
Table 69. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 70. GenScript Recent Development
Table 71. Pfizer Inc Company Details
Table 72. Pfizer Inc Business Overview
Table 73. Pfizer Inc Recombinant DNA (rDNA) Technology Product
Table 74. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 75. Pfizer Inc Recent Development
Table 76. Novo Nordisk A/S Company Details
Table 77. Novo Nordisk A/S Business Overview
Table 78. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product
Table 79. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 80. Novo Nordisk A/S Recent Development
Table 81. Eli Lilly and Company Company Details
Table 82. Eli Lilly and Company Business Overview
Table 83. Eli Lilly and Company Recombinant DNA (rDNA) Technology Product
Table 84. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 85. Eli Lilly and Company Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Recombinant DNA (rDNA) Technology Product
Table 89. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Biocon Company Details
Table 92. Biocon Business Overview
Table 93. Biocon Recombinant DNA (rDNA) Technology Product
Table 94. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 95. Biocon Recent Development
Table 96. GlaxoSmithKline plc Company Details
Table 97. GlaxoSmithKline plc Business Overview
Table 98. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product
Table 99. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 100. GlaxoSmithKline plc Recent Development
Table 101. New England Biolabs. Company Details
Table 102. New England Biolabs. Business Overview
Table 103. New England Biolabs. Recombinant DNA (rDNA) Technology Product
Table 104. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 105. New England Biolabs. Recent Development
Table 106. Cibus Company Details
Table 107. Cibus Business Overview
Table 108. Cibus Recombinant DNA (rDNA) Technology Product
Table 109. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 110. Cibus Recent Development
Table 111. Monsanto Company Company Details
Table 112. Monsanto Company Business Overview
Table 113. Monsanto Company Recombinant DNA (rDNA) Technology Product
Table 114. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 115. Monsanto Company Recent Development
Table 116. Horizon Discovery Group PLC Company Details
Table 117. Horizon Discovery Group PLC Business Overview
Table 118. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product
Table 119. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 120. Horizon Discovery Group PLC Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Recombinant DNA (rDNA) Technology Picture
Figure 2. Global Recombinant DNA (rDNA) Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant DNA (rDNA) Technology Market Share by Type: 2024 VS 2031
Figure 4. Expression System Features
Figure 5. Cloning Vector Features
Figure 6. Global Recombinant DNA (rDNA) Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology and Pharmaceutical Companies Case Studies
Figure 9. Academic and Government Research Institutes Case Studies
Figure 10. Other Case Studies
Figure 11. Recombinant DNA (rDNA) Technology Report Years Considered
Figure 12. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Recombinant DNA (rDNA) Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Recombinant DNA (rDNA) Technology Market Share by Region: 2024 VS 2031
Figure 15. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2024
Figure 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2024
Figure 18. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 20. United States Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 24. Germany Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Region (2020-2031)
Figure 32. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 40. Mexico Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 44. Turkey Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 48. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 49. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 51. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 52. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 53. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 55. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 56. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 57. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 58. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 59. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 60. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 61. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Expression System
Table 3. Key Players of Cloning Vector
Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Recombinant DNA (rDNA) Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Recombinant DNA (rDNA) Technology Market Share by Region (2020-2025)
Table 8. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Recombinant DNA (rDNA) Technology Market Share by Region (2026-2031)
Table 10. Recombinant DNA (rDNA) Technology Market Trends
Table 11. Recombinant DNA (rDNA) Technology Market Drivers
Table 12. Recombinant DNA (rDNA) Technology Market Challenges
Table 13. Recombinant DNA (rDNA) Technology Market Restraints
Table 14. Global Recombinant DNA (rDNA) Technology Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Players (2020-2025)
Table 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2024)
Table 17. Ranking of Global Top Recombinant DNA (rDNA) Technology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Recombinant DNA (rDNA) Technology Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Recombinant DNA (rDNA) Technology, Headquarters and Area Served
Table 20. Global Key Players of Recombinant DNA (rDNA) Technology, Product and Application
Table 21. Global Key Players of Recombinant DNA (rDNA) Technology, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant DNA (rDNA) Technology Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2020-2025)
Table 25. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2026-2031)
Table 27. Global Recombinant DNA (rDNA) Technology Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2020-2025)
Table 29. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2026-2031)
Table 31. North America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
Table 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
Table 48. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product
Table 49. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
Table 51. Profacgen Company Details
Table 52. Profacgen Business Overview
Table 53. Profacgen Recombinant DNA (rDNA) Technology Product
Table 54. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 55. Profacgen Recent Development
Table 56. Amgen Inc Company Details
Table 57. Amgen Inc Business Overview
Table 58. Amgen Inc Recombinant DNA (rDNA) Technology Product
Table 59. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 60. Amgen Inc Recent Development
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Recombinant DNA (rDNA) Technology Product
Table 64. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. GenScript Company Details
Table 67. GenScript Business Overview
Table 68. GenScript Recombinant DNA (rDNA) Technology Product
Table 69. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 70. GenScript Recent Development
Table 71. Pfizer Inc Company Details
Table 72. Pfizer Inc Business Overview
Table 73. Pfizer Inc Recombinant DNA (rDNA) Technology Product
Table 74. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 75. Pfizer Inc Recent Development
Table 76. Novo Nordisk A/S Company Details
Table 77. Novo Nordisk A/S Business Overview
Table 78. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product
Table 79. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 80. Novo Nordisk A/S Recent Development
Table 81. Eli Lilly and Company Company Details
Table 82. Eli Lilly and Company Business Overview
Table 83. Eli Lilly and Company Recombinant DNA (rDNA) Technology Product
Table 84. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 85. Eli Lilly and Company Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Recombinant DNA (rDNA) Technology Product
Table 89. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Biocon Company Details
Table 92. Biocon Business Overview
Table 93. Biocon Recombinant DNA (rDNA) Technology Product
Table 94. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 95. Biocon Recent Development
Table 96. GlaxoSmithKline plc Company Details
Table 97. GlaxoSmithKline plc Business Overview
Table 98. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product
Table 99. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 100. GlaxoSmithKline plc Recent Development
Table 101. New England Biolabs. Company Details
Table 102. New England Biolabs. Business Overview
Table 103. New England Biolabs. Recombinant DNA (rDNA) Technology Product
Table 104. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 105. New England Biolabs. Recent Development
Table 106. Cibus Company Details
Table 107. Cibus Business Overview
Table 108. Cibus Recombinant DNA (rDNA) Technology Product
Table 109. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 110. Cibus Recent Development
Table 111. Monsanto Company Company Details
Table 112. Monsanto Company Business Overview
Table 113. Monsanto Company Recombinant DNA (rDNA) Technology Product
Table 114. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 115. Monsanto Company Recent Development
Table 116. Horizon Discovery Group PLC Company Details
Table 117. Horizon Discovery Group PLC Business Overview
Table 118. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product
Table 119. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
Table 120. Horizon Discovery Group PLC Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Recombinant DNA (rDNA) Technology Picture
Figure 2. Global Recombinant DNA (rDNA) Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant DNA (rDNA) Technology Market Share by Type: 2024 VS 2031
Figure 4. Expression System Features
Figure 5. Cloning Vector Features
Figure 6. Global Recombinant DNA (rDNA) Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology and Pharmaceutical Companies Case Studies
Figure 9. Academic and Government Research Institutes Case Studies
Figure 10. Other Case Studies
Figure 11. Recombinant DNA (rDNA) Technology Report Years Considered
Figure 12. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Recombinant DNA (rDNA) Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Recombinant DNA (rDNA) Technology Market Share by Region: 2024 VS 2031
Figure 15. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2024
Figure 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2024
Figure 18. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 20. United States Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 24. Germany Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Region (2020-2031)
Figure 32. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 40. Mexico Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
Figure 44. Turkey Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 48. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 49. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 51. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 52. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 53. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 55. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 56. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 57. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 58. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 59. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 60. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 61. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232